US HUMIRA Market Projected for Extensive Growth by 2032 in Noninfectious Autoimmune Uveitis Sector
28 févr. 2024 11h05 HE
|
Research and Markets
Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The "US HUMIRA Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering. An insightful analysis...
Psoriasis Global Market Report 2024: Market to Surge to $39.17 Billion by 2028, Middle East Poised for Rapid Growth - Long-term Forecasts to 2033
26 janv. 2024 03h17 HE
|
Research and Markets
Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Psoriasis Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The psoriasis market is undergoing significant...
Generalized Pustular Psoriasis (GPP) Competitive Landscape Report, Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
18 janv. 2024 09h58 HE
|
Research and Markets
Dublin, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The "Generalized Pustular Psoriasis (GPP) - Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.This reports provides a...
Liposomal Cyclosporine A Emerging Drug Insights and Market Forecasts, 2017-2023 & 2023-2032: Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan
22 nov. 2023 09h08 HE
|
Research and Markets
Dublin, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The "Liposomal Cyclosporine A Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report...
Biologics and Personalized Medicine to Fuel Growth in the Plaque Psoriasis Treatment Market, With Telemedicine and Digital Health Playing a Role
22 sept. 2023 08h43 HE
|
Research and Markets
Dublin, Sept. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Plaque Psoriasis Treatment Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering. The global...
Adalimumab Global Market Report 2022: Rising Prevalence of Arthritis and Clinical Trials to Spur Growth
22 févr. 2023 09h33 HE
|
Research and Markets
Dublin, Feb. 22, 2023 (GLOBE NEWSWIRE) -- The "Adalimumab Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028: Segmented By Type (Biologics v/s Biosimilars), By...
Adalimumab, Infliximab And Etanercept Biosimilars Global Market Report 2023: Increasing Healthcare Access Bolsters Sector
11 janv. 2023 04h48 HE
|
Research and Markets
Dublin, Jan. 11, 2023 (GLOBE NEWSWIRE) -- The "Adalimumab, Infliximab And Etanercept Biosimilars Global Market Opportunities And Strategies To 2031" report has been added to ...
Adalimumab, Infliximab and Etanercept Biosimilars Global Market Report 2022: Featuring Zydus Cadila, Abbvie, Samsung Bioepis & More
18 nov. 2022 08h08 HE
|
Research and Markets
Dublin, Nov. 18, 2022 (GLOBE NEWSWIRE) -- The "Adalimumab, Infliximab and Etanercept Biosimilars Global Market Report 2022: By Product, By Application, By Distribution" report has been added to ...
China Infliximab Market Investigation Report 2022: Sales 2017-2021, Major Manufacturers 2017-2021, Prices for Different Manufacturers 2021-2022 and Prospects 2022-2031
10 août 2022 05h28 HE
|
Research and Markets
Dublin, Aug. 10, 2022 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Infliximab Market 2022-2031" report has been added to ResearchAndMarkets.com's offering. According to this market...
Global Psoriasis Therapeutics Market Report to 2028 - Industry Analysis, Trends, Size, and Forecasts
20 juin 2022 06h33 HE
|
Research and Markets
Dublin, June 20, 2022 (GLOBE NEWSWIRE) -- The "Psoriasis Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028" report has been added to...